Pathologic, cytogenetic and molecular assessment of acute promyelocytic leukemia (APL) patients treated with arsenic trioxide (As2O3,)

被引：0
|
作者：
Zhang, T [1 ]
Westervelt, P [1 ]
Hess, JL [1 ]
机构：
[1] Univ Washington, Sch Med, St Louis, MO USA
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
876
引用
收藏
页码：150A / 150A
页数：1
相关论文
共 50 条
  • [31] Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide
    Miller, Karin P.
    Venkataraman, Girish
    Gocke, Christopher D.
    Batista, Denise A.
    Borowitz, Michael J.
    Burns, Kathleen H.
    Pratz, Keith
    Duffield, Amy S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (05) : 675 - 685
  • [32] Bone Marrow Findings in Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide
    Duffield, Amy
    Miller, Karin P.
    LABORATORY INVESTIGATION, 2018, 98 : 512 - 512
  • [33] Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide
    Westervelt, P
    Brown, RA
    Adkins, DR
    Khoury, H
    Curtin, P
    Hurd, D
    Luger, SM
    Ma, MK
    Ley, TJ
    DiPersio, JF
    BLOOD, 2001, 98 (02) : 266 - 271
  • [34] All-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) combination therapy induces high rates of durable molecular remission in newly diagnosed acute, promyelocytic leukemia (APL)
    Tsimberidou, Apostolia-Maria
    Kantarjian, Hagop
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Koller, Charles
    Jones, Daniel
    Pierce, Sherry
    Brandt, Mark
    Keating, Michael
    Estey, Estey
    BLOOD, 2007, 110 (11) : 543A - 543A
  • [35] Assessment of arsenic trioxide (AS2O3) effect on telomerase activity in acute promyelocytic leukaemia patients and NB4 cell line
    Ghaffari, SH
    Jamialahmadi, AH
    Shayan-Asl, N
    Alimoghaddam, K
    Ghavamzadeh, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S123 - S123
  • [36] Arsenic trioxide metabolism in patients with acute promyelocytic leukemia
    Khan, Mohammad T.
    Tariq, Sara
    Ghiuzeli, Cristina M.
    Styblo, Miroslav
    Saunders, Jesse
    Calabro, Anthony
    Kohn, Nina
    Budman, Daniel
    Allen, Steven
    Devoe, Craig
    CANCER RESEARCH, 2017, 77
  • [37] Determination of arsenic metabolites in patients with newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide
    Zhang, Zhuo
    Chen, Yan
    Meng, Hongbin
    Sui, Meijuan
    Zhou, Qian
    Shi, Ce
    Han, Lina
    Wang, Hong
    Zhou, Jin
    LEUKEMIA & LYMPHOMA, 2013, 54 (09) : 2041 - 2046
  • [38] Evaluation of arsenic species in leukocytes and granulocytes of acute promyelocytic leukemia patients treated with arsenic trioxide
    Wang, Xinyu
    Qian, Zhao
    Li, Haitao
    Chen, Hongzhu
    Lin, Liwang
    Guo, Meihua
    Hai, Xin
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2021, 203
  • [39] Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
    Akihiro Tomita
    Hitoshi Kiyoi
    Tomoki Naoe
    International Journal of Hematology, 2013, 97 : 717 - 725
  • [40] Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in acute promyelocytic leukemia
    Tomita, Akihiro
    Kiyoi, Hitoshi
    Naoe, Tomoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (06) : 717 - 725
12345